SCHEMBL896216

SCHEMBL896216

Cc1[c]ncc(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1153503 0.74
SCHEMBL1637855 0.74
SCHEMBL595695 0.74
SCHEMBL1636157 0.74
SCHEMBL1036274 0.74
SCHEMBL595676 0.74
SCHEMBL359307 0.74
SCHEMBL356912 0.74
SCHEMBL1637730 0.72
SCHEMBL1638085 0.72 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-06-27 US claimed
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-10-31 US claimed
EP-4217062-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-08-02 EP claimed
CN-116323557-A Cyclobutylamide monoacylglycerol lipase modulators 詹森药业有限公司 2023-06-23 CN claimed
EP-3166917-B1 METHOD OF PREPARING AROMATIC COMPOUNDS FROM LIGNIN COMMISSARIAT ENERGIE ATOMIQUE (FR) 2021-04-21 EP claimed
EP-3166916-B1 METHOD OF DEPOLYMERIZING LIGNIN COMMISSARIAT ENERGIE ATOMIQUE (FR) 2021-02-24 EP claimed
CN-110229141-A A kind of novel preparation method of high-purity esomeprazole sodium 福安药业集团重庆博圣制药有限公司 2019-09-13 CN claimed
US-10370315-B2 Method of depolymerizing lignin COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2019-08-06 US claimed
EP-3233996-B1 METHOD FOR DEPOLYMERISING OXYGENATED POLYMER MATERIALS COMMISSARIAT ENERGIE ATOMIQUE (FR) 2019-04-03 EP claimed
US-10189868-B2 Method for depolymerising oxygenated polymer materials COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2019-01-29 US claimed
EP-1313713-B1 4-PYRIMIDINAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS ORTHO MCNEIL PHARM INC (US) 2008-06-11 EP claimed
US-20070244128-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-10-18 US claimed
US-20070219206-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-09-20 US claimed
US-20050203092-A1 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods BENJAMIN ELFRIDA R (US) 2005-09-15 US claimed
US-20040006094-A1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods GRANT ELFRIDA R (US) 2004-01-08 US claimed
US-20030212079-A1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods GRANT ELFRIDA R (US) 2003-11-13 US claimed
EP-1313713-A2 4-PYRIMIDINAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-05-28 EP claimed
US-20030008883-A1 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-01-09 US claimed
WO-2002012198-A2 4-PYRIMIDINAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2002-02-14 WO claimed
US-4428935-A BETA-LACTAMASE INHIBITORS PFIZER INC. (US) 1984-01-31 US claimed